
Rivaroxaban does not increase the risk of fatal gastrointestinal bleeding
Although rivaroxaban was associated with a higher risk of gastrointestinal bleeding (GI) than warfarin, the incidence of severe gastrointestinal bleeding was similar in both groups, with few fatal bleeding events.